[Progress in the treatment of chronic hepatitis B with Telbivudine].
Xu
Jie
J
Department of Infectious Diseases, Third Pepole' Hospital and Ruijin Hospital Affiliated to Medical School of Shanghai Jiaotong University, Shanghai 201900, China. evexj@yahoo.com.cn
Lu
Zhi-Meng
ZM
D000998:Antiviral Agents / Q000627:therapeutic use*; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use*; D011744:Pyrimidinones / Q000627:therapeutic use*; D000077712:Telbivudine; D013936:Thymidine / Q000031:analogs & derivatives
D000998:Antiviral Agents; D009705:Nucleosides; D011744:Pyrimidinones; D000077712:Telbivudine; D013936:Thymidine